CN Patent

CN115836054B — Il4i1抑制剂和使用方法

Assigned to Merck Sharp and Dohme BV · Expires 2024-12-10 · 1y expired

What this patent protects

本文描述了式I的化合物或其药学上可接受的盐。式I的化合物充当IL4I1抑制剂并且可以用于预防、治疗IL4I1相关疾病或充当IL4I1相关疾病的治疗剂。

USPTO Abstract

本文描述了式I的化合物或其药学上可接受的盐。式I的化合物充当IL4I1抑制剂并且可以用于预防、治疗IL4I1相关疾病或充当IL4I1相关疾病的治疗剂。

Drugs covered by this patent

pasireotide-pamoate (PASIREOTIDE PAMOATE)

Patent Metadata

Patent number: CN115836054B
Jurisdiction: CN
Classification: —
Expires: 2024-12-10
Drug substance claim: No
Drug product claim: No
Assignee: Merck Sharp and Dohme BV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.